Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Influenza
Related studies linked through entity extraction aliases.
Optimizing Influenza Vaccination in Surgical Oncology Patients
- Status
- UNKNOWN
- Phase
- PHASE4
Effectiveness Assessment of Vaccinating Schoolchildren Against Influenza
- Status
- COMPLETED
- Phase
- PHASE4
Study of Fluzone® Influenza Virus Vaccines 2012-2013 Formulation Among Adults.
- Status
- COMPLETED
- Phase
- PHASE4
Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Influenza Virus Vaccine (2012-2013 Formulation)
- Status
- COMPLETED
- Phase
- PHASE4
Panama and El Salvador Children's Oseltamivir Study
- Status
- TERMINATED
- Phase
- PHASE4
Safety Study of an Oral Vaccine to Prevent Seasonal Influenza
- Status
- COMPLETED
- Phase
- PHASE1
Comparison of Epidemiology and Clinical Outcomes of Influenza A & B Cases in Manitoba, Canada
- Status
- COMPLETED
- Phase
- N/A
ADITEC FLU STUDY: Understanding the Genetic Basis for Immune Responses
- Status
- COMPLETED
- Phase
- PHASE2
Influenza Immunization of Children in India
- Status
- COMPLETED
- Phase
- PHASE4
Study to Investigate the Efficacy and Safety of Apomivir®
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Seasonal Influenza HA DNA With Trivalent Inactivated Vaccine (TIV) Administered ID or IM in Healthy Adults 18-70 Years
- Status
- COMPLETED
- Phase
- PHASE1
Evaluating Immune Response to Seasonal FluMist in Healthy Adults
- Status
- TERMINATED
- Phase
- NA
A Time-motion Study Comparing Self- to Nurse-vaccination With Influenza Vaccine
- Status
- COMPLETED
- Phase
- PHASE4
From Innovation to Solutions: Childhood Influenza Vaccination Planning
- Status
- COMPLETED
- Phase
- NA
Vaccine Health Literacy Related Text Message Reminders to Increase Receipt of Second Dose of Influenza Vaccine for Young, Low Income, Urban Children
- Status
- COMPLETED
- Phase
- NA
Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccines GSK2654911A and GSK2654909A Administered to Adults 18 to 64 Years of Age
- Status
- COMPLETED
- Phase
- PHASE1
Study of the Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Immunogenicity Study of Split Influenza Virus Vaccine in Different Age Groups
- Status
- COMPLETED
- Phase
- PHASE4
Randomized Trial of High Dose Influenza Vaccine in Long Term Care Setting
- Status
- COMPLETED
- Phase
- PHASE4